All About Cases And Settlements Involving Invokana
Invokana is an SGLT2 inhibitor designed to block a specific protein that helps the body reabsorb glucose in the bloodstream. Sadly, many patients who are prescribed Invokana to treat their Type-II diabetes have experienced serious complications, often resulting fatal. Many lawsuits have been filed against the manufacturer. Invokana lawsuit update claims that the drug manufacturer didn’t warn the patients and physicians about the possible side effects. The legal papers plainly insist that if the drug manufacturer had prior and adequate warnings against Invokana and its side effects, the physicians would have informed the patients of the risks, if prescribed at all. Some of the most prominent cases involving Invokana are: September 2015: An Invokana lawsuit for $1 billion (general and special damages more than $500 million each) was filed on behalf of Canadians in Ontario. Under a request for class-action status, the manufacturers involve a woman who too